US · Healthcare

Atara Biotherapeutics Inc (ATRA)

Biotechnology

Atara Biotherapeutics Inc (ATRA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ATRA

P/E ratio

25.00

Atara Biotherapeutics Inc (ATRA) — FAQ

What is ATRA's P/E ratio?

The price-to-earnings (P/E) ratio for Atara Biotherapeutics Inc (ATRA) is 25.00 (data as of 2026-05-23).

Does Atara Biotherapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Atara Biotherapeutics Inc (ATRA). Check the MyAverix Finance app for the latest dividend data.

What sector is Atara Biotherapeutics Inc in?

Atara Biotherapeutics Inc (ATRA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ATRA listed on?

ATRA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)